Prediction and validation of the structural features of Ov58GPCR, an immunogenic determinant of Onchocerca volvulus.
Onchocerciasis is a severely debilitating yet neglected tropical disease (NTD) that creates social stigma, generates and perpetuates poverty, and leads ultimately in some cases to irreversible unilateral or bilateral blindness if untreated. Consequently, the disease is a major impediment to socioeco...
Main Authors: | Robert Adamu Shey, Stephen Mbigha Ghogomu, Ferdinand Ngale Njume, Lea Olive Tchouate Gainkam, Philippe Poelvoorde, Leon Mutesa, Annie Robert, Perrine Humblet, Jean-Pierre Munyampundu, Joseph Kamgno, Christophe Lelubre, Luc Vanhamme, Jacob Souopgui |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6157839?pdf=render |
Similar Items
-
Identification and characterization of the Onchocerca volvulus Excretory Secretory Product Ov28CRP, a putative GM2 activator protein.
by: Ferdinand Ngale Njume, et al.
Published: (2019-07-01) -
The Functional Parasitic Worm Secretome: Mapping the Place of <i>Onchocerca volvulus</i> Excretory Secretory Products
by: Luc Vanhamme, et al.
Published: (2020-11-01) -
The Immunomodulatory Role of Adjuvants in Vaccines Formulated with the Recombinant Antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in Mice.
by: Jessica A Hess, et al.
Published: (2016-07-01) -
In Silico Design and Validation of OvMANE1, a Chimeric Antigen for Human Onchocerciasis Diagnosis
by: Cabirou Mounchili Shintouo, et al.
Published: (2020-06-01) -
Antibody responses against the vaccine antigens Ov-103 and Ov-RAL-2 are associated with protective immunity to Onchocerca volvulus infection in both mice and humans.
by: Parakkal Jovvian George, et al.
Published: (2019-09-01)